Antibodies to tetanus toxoid in women of childbearing age in Dar es Salaam and Bagamoyo, Tanzania

被引:10
作者
Aboud, S
Matre, R
Lyamuya, EF
Kristoffersen, EK
机构
[1] Univ Bergen, Gade Inst, Dept Microbiol & Immunol, N-5021 Bergen, Norway
[2] Muhimbili Univ, Coll Hlth Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania
关键词
tetanus toxoid; immunization; vaccination; neonatal tetanus; antibody avidity; avidity index;
D O I
10.1046/j.1365-3156.2001.00697.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our aim was to determine tetanus immunity in women of childbearing age (15-44 years) with histories and/or documentation of having been vaccinated with Tetanus Toroid (TT) under the Expanded Programme on Immunization in Dar es Salaam and Bagamoyo, Tanzania. Using an ELISA technique, serum Levels of TT antibody, antibody avidity and distribution of TT IgG subclass antibodies were determined in 207 apparently healthy women. A TT antibody level of 0.1 IU/ml was considered protective. 99% and 100% of women in Dar es Salaam and Bagamoyo, respectively, had a TT antibody level greater than or equal to0.1 IU/ml. Anti-toxin binding avidity was found to be high in most of the women. In addition to TT IgG3 subclass antibody, TT IgG1 subclass antibody was the most dominant subclass type. A substantial number of women also had TT IgG2 and TT 1gG4 subclass antibody responses. A better recording system on TT immunization is recommended to avoid hyper-immunization of women and to optimize the cost-effectiveness of the immunization programme.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 33 条
  • [1] ABACIOGLU YH, 1995, FEMS IMMUNOL MED MIC, V11, P273, DOI 10.1016/0928-8244(95)00033-4
  • [2] Anh N Q, 1999, Dev Biol Stand, V101, P247
  • [3] TRADITIONAL MIDWIVES, TETANUS IMMUNIZATION, AND INFANT-MORTALITY IN RURAL HAITI
    BERGGREN, GG
    BERGGREN, W
    VERLY, A
    GARNIER, N
    PETERSON, W
    EWBANK, D
    DIEUDONNE, W
    [J]. TROPICAL DOCTOR, 1983, 13 (02) : 79 - 87
  • [4] BIZZINI B, 1978, ANN INST PASTEUR MIC, VB129, P437
  • [5] BLACK RE, 1980, B WORLD HEALTH ORGAN, V58, P927
  • [6] CHRISTENSON B, 1987, SCAND J INFECT DIS, V19, P429, DOI 10.3109/00365548709021675
  • [7] COLLIER LH, 1979, LANCET, V1, P1364
  • [8] CUTTS F, 1990, B WORLD HEALTH ORGAN, V68, P199
  • [9] EDSALL GEOFFREY, 1967, J AMER MED ASS, V202, P111, DOI 10.1001/jama.202.1.111
  • [10] *EXP PROGR IMM, 1982, WEEKLY EPIDEMIOLOGIC, V27, P1327